If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Acquisition

5 Jan 2026 07:19

RNS Number : 6254N
Compagnie de Saint-Gobain
05 January 2026
 

Saint-Gobain strengthens its presencein construction chemicals in Indonesia

 

On December 30, 2025 Saint-Gobain formed a JV with a subsidiary of Indocement Tunggal Prakarsa (a publicly traded Indonesian cement company 53% owned by Heidelberg Materials) to acquire Indocement's mortars business in Indonesia. The JV will be 60% held by Saint-Gobain with the remaining 40% held by Indocement Tunggall Prakarsa.

 

Indocement's mortars business is well-established in Indonesia with three production lines under the Tiga Roda brand and estimated sales of close to €20 million in 2025. Tiga Roda is a leading brand in white skim coat for finishing and is very complementary to Saint-Gobain's existing mortars business, Cipta Mortar Utama (CMU), both in product categories and geographic reach, strengthening customer intimacy across Indonesia.

 

Saint-Gobain has been present in Indonesia since 1995 and currently operates 14 production lines and employs around 1,300 people in the country. CMU is the leading player on the Indonesian market, thanks to 8 mortars production lines across the country, a comprehensive product portfolio and a network of close to 30,000 points of sale. CMU also benefits from Saint-Gobain's large presence across construction chemicals in Indonesia, thanks to its GCP (concrete admixtures and cement additives) and FOSROC (cement additives, resin flooring and technical mortars) brands.

 

The newly formed JV will leverage the strengths of Saint-Gobain's CMU, as well as those of Indocement, a leading cement manufacturer in Indonesia, to accelerate growth on the promising mortars market.

 

This acquisition is part of Saint-Gobain's strategy to further strengthen its business profile, in line with its "Lead & Grow" plan. It enhances Saint-Gobain's presence in the high-growth Indonesian market and is fully aligned with the Group's strategy to strengthen its worldwide presence in construction chemicals.

 

 

About Saint-Gobain

Worldwide leader in light and sustainable construction, Saint-Gobain designs, manufactures and distributes materials and services for the construction and industrial markets. Its integrated solutions for the renovation of public and private buildings, light construction and the decarbonization of construction and industry are developed through a continuous innovation process and provide sustainability and performance. The Group, celebrating its 360th anniversary in 2025, remains more committed than ever to its purpose "MAKING THE WORLD A BETTER HOME".

 

€46.6 billion in sales in 2024

More than 161,000 employees, locations in 80 countries

Committed to achieving net zero carbon emissions by 2050

 

For more information about Saint-Gobain, visit www.saint-gobain.com and follow us on X @saintgobain

 

 

Analyst/investor relations

Press relations

Vivien Dardel:

+33 1 88 54 29 77

Patricia Marie:

+33 1 88 54 26 83

Floriana Michalowska:

+33 1 88 54 19 09

Laure Bencheikh:

+33 1 88 54 26 38

Karim Safsaf:

+33 1 88 54 00 60

Yanice Biyogo:

 +33 1 88 54 27 96

James Weston: 

+33 1 88 54 01 24

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQBAMRTMTBMMIF
Date   Source Headline
15th Sep 20146:30 pmRNSFinal Terms
5th Sep 20148:01 amRNSJV Saint-Gobain Central Glass in Indonesia
8th Aug 20144:07 pmRNSProspectus supplement
1st Aug 20148:34 amRNSAcquisition
30th Jul 20145:27 pmRNSH1-2014 Results
28th Jul 20147:52 amRNSNew contracts in Qatar
18th Jul 20148:13 amRNSPublication of Prospectus
7th Jul 20145:43 pmRNSAgreement Saint-Gobain / EBRD
2nd Jul 20145:10 pmRNSResult of the 2013 scrip dividend
17th Jun 201410:25 amRNSAcquisition
5th Jun 20146:21 pmRNSAdoption of all resolutions & reappointment of CEO
3rd Jun 20148:15 amRNSJoin Venture
29th Apr 20145:03 pmRNS1st Quarter Results
11th Apr 20144:54 pmRNSDisposal
27th Mar 20149:22 amRNSDecision of the General Court of the EU
4th Mar 20149:19 amRNSProspectus Supplement
19th Feb 20146:08 pmRNSFinal Results
19th Dec 20134:46 pmRNSDisposal
17th Dec 20134:49 pmRNSundrawn bank facilities
4th Dec 20134:50 pmRNSAcquisition
2nd Dec 20134:46 pmRNSSecuritisation programme
28th Nov 20137:00 amRNSFinal Terms
28th Nov 20137:00 amRNSFinal Terms
27th Nov 20136:08 pmRNSInvestor Meeting
25th Nov 20137:00 amRNSFinal Terms
25th Nov 20137:00 amRNSFinal terms
25th Nov 20137:00 amRNSFinal Terms
22nd Nov 20137:00 amRNSDirector renewal
24th Oct 20134:46 pmRNS3rd Quarter Results
30th Sep 20135:53 pmRNSFinal Terms
30th Sep 20137:00 amRNSR&D Center
6th Aug 20137:00 amRNSProspectus supplement
31st Jul 20133:23 pmRNSH1-2013 Financial Report
24th Jul 20135:10 pmRNSHalf Year Results
18th Jul 20138:40 amRNSProspectus
11th Jul 201311:30 amRNSNew plant in Russia
3rd Jul 20134:58 pmRNS2012 dividend
2nd Jul 20138:34 amRNSDisposal
6th Jun 20136:34 pmRNSFinal Terms
6th Jun 20136:25 pmRNSAGM Statement
30th May 20131:28 pmRNSCORRECTIONS TO FINAL TERMS
25th Apr 20135:16 pmRNS1st Quarter Results
9th Apr 20135:11 pmRNSContract in Kuwait
5th Apr 20132:43 pmRNSFinal Terms
5th Apr 20132:43 pmRNSFinal Terms
2nd Apr 201311:08 amRNSDoc Re: Prospectus Supplement
18th Mar 201310:23 amRNSFY 2012 Consolidated Financial Statements
7th Mar 20139:00 amRNSDisposal
6th Mar 20134:48 pmRNSNew plant
21st Feb 20137:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.